Oxadiazoles
eMolecules 229625-50-7 | Di-tert-butyl chloromethyl phosphate | Combi-Blocks | MFCD12165895 | 258.680 | C9H20ClO4P | 97.000 | CC(C)(C)OP(=O)(OCCl)OC(C)(C)C | 5g | 205413400
Di-tert-butyl chloromethyl phosphate | Combi-Blocks | 229625-50-7 | MFCD12165895 | 258.680 | C9H20ClO4P | 97.000 | CC(C)(C)OP(=O)(OCCl)OC(C)(C)C | 5g | 205413400
![Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 | C17H23N3O | 25 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000242717.png-250.jpg)
Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 | C17H23N3O | 25 MG
PSN 375963 is a small-molecule agonist of the G protein-coupled receptor GPR119 used as a research tool to study GPR119-mediated signaling and metabolic effects. It is supplied as a characterized solid for in vitro and preclinical investigations.
- Potent GPR119 agonist with human EC50 8.4 μM and mouse EC50 7.9 μM.
- Chemical formula C17H23N3O; molecular weight 285.38 g/mol.
- Solid, white to off-white appearance, suitable for assay use.
- High purity (≈99.96%) by HPLC.
- Recommended storage: powder -20°C (long term) or 4°C (short term); in solvent -80°C.
![Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000242673.png-250.jpg)
Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 5 MG
PSN 375963 is a small-molecule agonist of G protein-coupled receptor 119 (GPR119) used as a research tool to probe GPR119 signaling and metabolic pathways. It is reported with low micromolar activity and is provided as a solid suitable for biochemical and cellular assays.
- Potent GPR119 agonist with EC50 ≈ 8.4 μM (human) and 7.9 μM (mouse).
- Small molecule with formula C17H23N3O and molecular weight 285.38 g·mol⁻¹.
- Supplied as a solid suitable for biochemical and cellular assays.
- High reported purity (99.96%).
- Used to study GPR119-mediated metabolic signaling and receptor pharmacology.
![eMolecules 1218790-54-5 | [1,2,5]Oxadiazolo[3,4-b]pyridin-6-ylboronic acid, pinacol ester | Combi-Blocks | MFCD11867869 | 247.060 | C11H14BN3O3 | 95.000 | CC1(C)OB(OC1(C)C)c1cnc2nonc2c1 | 1g | 117546937](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00128114-117546937.PNG-250.jpg)
eMolecules 1218790-54-5 | [1,2,5]Oxadiazolo[3,4-b]pyridin-6-ylboronic acid, pinacol ester | Combi-Blocks | MFCD11867869 | 247.060 | C11H14BN3O3 | 95.000 | CC1(C)OB(OC1(C)C)c1cnc2nonc2c1 | 1g | 117546937
[1,2,5]Oxadiazolo[3,4-b]pyridin-6-ylboronic acid, pinacol ester | Combi-Blocks | 1218790-54-5 | MFCD11867869 | 247.060 | C11H14BN3O3 | 95.000 | CC1(C)OB(OC1(C)C)c1cnc2nonc2c1 | 1g | 117546937
eMolecules 388575-52-8 | Medchem Express | PSN 375963 | 5mg | 601586505 | HY-108258 | MFCD01829706 | 285.391 | C17H23N3O
Pharmablock | 5-methylimidazo[12-a]pyridine-2-carboxylic acid | 25mg | 718093539 | PB1233059 | 88751-06-8 | MFCD03419472 | 176.175 | C9H8N2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
eMolecules 229625-50-7 | DI-TERT-BUTYL CHLOROMETHYL PHOSPHATE (CONTAINS 2-5%K2CO3 AS STABILIZER) | AstaTech | MFCD12165895 | 258.680 | C9H20ClO4P | 95.000 | CC(C)(C)OP(=O)(OCCl)OC(C)(C)C | 1kg | 929740861
DI-TERT-BUTYL CHLOROMETHYL PHOSPHATE (CONTAINS 2-5%K2CO3 AS STABILIZER) | AstaTech | 229625-50-7 | MFCD12165895 | 258.680 | C9H20ClO4P | 95.000 | CC(C)(C)OP(=O)(OCCl)OC(C)(C)C | 1kg | 929740861
Apexbio Technology LLC ODQ 41443-28-1 10mg
ODQ (CAS 41443-28-1) is a selective inhibitor of soluble guanylate cyclase (sGC) interfering with nitric oxide (NO)-dependent intracellular signaling by blocking sGC-mediated catalysis of cyclic guanosine monophosphate (cGMP) synthesis This inhibition results in reduced cGMP production and subsequent modulation of protein kinase G-regulated cellular processes Studies have demonstrated that ODQ enhances cisplatin-induced apoptosis in human mesothelioma cells in vitro supporting its use in investigating tumor cell apoptosis mechanisms and evaluating synergistic effects in anticancer drug research
Medchemexpress LLC 1,3,4-oxadiazole | 288-99-3 | MFCD00955535 | 99.8% | 70.05 g·mol⁻¹ | C2H2N2O | 500 MG
1,3,4-Oxadiazole is a small heterocyclic compound used as a synthetic building block in medicinal chemistry and organic synthesis. It is provided at high purity for research use and is suitable as an intermediate or scaffold in small-molecule synthesis.
- High purity for research applications (99.8%).
- Colorless to light yellow liquid; density 0.97 g·cm⁻³.
- Stable when stored under recommended conditions.
- Useful scaffold for heterocycle synthesis and library design.
- Available in multiple laboratory pack sizes for flexibility.
- Supplied for research use only.
Medchemexpress LLC 5-Chloromethyl-1-propyl-1H-imidazole hydrochloride | 497223-15-1 | 95.0% | 195.09 | 100 MG
5-Chloromethyl-1-propyl-1H-imidazole hydrochloride is a drug intermediate used for the synthesis of various active compounds. It is intended for research use only and not for sale to patients.
![Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000242681.png-250.jpg)
Medchemexpress LLC 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]pyridine | 388575-52-8 | MFCD01829706 | 100.0% | 285.38 g·mol⁻¹ | C17H23N3O | 100 MG
PSN 375963 is a small-molecule agonist of the G protein-coupled receptor GPR119 used as a research tool for in vitro pharmacology. It exhibits micromolar potency and is provided with supporting analytical documentation for use in biochemical and cell-based assays.
- Shows micromolar agonist activity at GPR119 (EC50s 8.4 μM human, 7.9 μM mouse).
- Supplied as a characterized research-grade compound with COA and SDS.
- Available as solid powder and DMSO solutions for assay flexibility.
- High purity suitable for biochemical and cell-based assays.
- Molecular formula C17H23N3O and molecular weight 285.38 g·mol⁻¹.
![Medchemexpress LLC 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | 41443-28-1 | MFCD00792620 | 99.8% | 187.16 g/mol | C9H5N3O2 | 1 ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000211707.png-250.jpg)
Medchemexpress LLC 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | 41443-28-1 | MFCD00792620 | 99.8% | 187.16 g/mol | C9H5N3O2 | 1 ML
ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) is a potent, selective inhibitor of soluble guanylyl cyclase (sGC) used in research to probe nitric oxide-cGMP signaling and related cellular processes. It is supplied in solution and solid formats for biochemical and cell-based studies.
- Potent and selective inhibitor of soluble guanylyl cyclase (sGC).
- Useful for studying nitric oxide-cGMP signaling in biochemical and cell-based assays.
- Enhances pro-apoptotic effects of cisplatin in certain cell models.
- Available as a 10 mM solution in DMSO (1 mL) and in multiple solid sizes.
- High purity (~99.8%) suitable for research applications.